Chilton Capital Management’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$188K Hold
20,426
0.01% 235
2026
Q1
$221K Sell
20,426
-542
-3% -$4.64K 0.01% 228
2025
Q4
$128K Hold
20,968
﹤0.01% 267
2025
Q3
$109K Hold
20,968
﹤0.01% 290
2025
Q2
$124K Hold
20,968
﹤0.01% 265
2025
Q1
$172K Hold
20,968
0.01% 233
2024
Q4
$173K Hold
20,968
0.01% 235
2024
Q3
$160K Hold
20,968
0.01% 243
2024
Q2
$217K Hold
20,968
0.01% 221
2024
Q1
$250K Hold
20,968
0.01% 219
2023
Q4
$226K Hold
20,968
0.01% 228
2023
Q3
$290K Buy
+20,968
New +$307K 0.02% 185

Other funds holding PTEN

Chilton Capital Management's PTEN Position: Q2 2026 in Review

Chilton Capital Management held its Patterson-UTI (PTEN) position steady in Q2 2026 at 20,426 shares worth $188K. The position accounts for 0.01% of the portfolio, ranked #235.

Chilton Capital Management first reported a position in PTEN in Q3 2023 and has held it in 12 quarters since. The position peaked at $290K in Q3 2023. 438 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Chilton Capital Management held 20,426 shares of Patterson-UTI worth $188K as of Q2 2026.
  • Chilton Capital Management left its Patterson-UTI share count unchanged in Q2 2026.
  • Patterson-UTI made up 0.01% of Chilton Capital Management's portfolio in Q2 2026, its #235 holding.
  • Chilton Capital Management first reported a position in Patterson-UTI in Q3 2023 and has held it in 12 quarters since.
  • Chilton Capital Management's Patterson-UTI position peaked at $290K in Q3 2023.
  • 438 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Chilton Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.